GLP-1 receptor agonists may increase the risk of bone and tendon injuries along with conditions such as osteoporosis and gout, a retrospective study suggested. …
Source link : https://www.medpagetoday.com/endocrinology/obesity/120213
Author :
Publish date : 2026-03-09 13:36:00
Copyright for syndicated content belongs to the linked Source.